Beta Bionics announces FDA clearance for Mint patch pump and algorithm
Beta Bionics receives FDA clearance for its new Mint patch pump and submitted the 3D Intelligence algorithm, shifting its commercialization timeline to 2026 and 2027 respectively while increasing manufacturing expectations for the new device.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day